Search Results
SAR131675 50mg 50mg | Purity Not Available
Adooq Bioscience
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
More Information Supplier PageSAR131675 25mg 25mg | Purity Not Available
Adooq Bioscience
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
More Information Supplier PageSAR131675 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
More Information Supplier PageSAR131675 100mg 100mg | Purity Not Available
Adooq Bioscience
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
More Information Supplier PageSAR131675 10mg 10mg | Purity Not Available
Adooq Bioscience
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
More Information Supplier PageCHC 500mg 500mg | Purity Not Available
Adooq Bioscience
CHC is a monocarboxylic acid transport (MCT) inhibitor. Exhibits antitumoral and antiangiogenic activity in gliomas; decreases glycolytic metabolism, migration, and invasion in U251 cells.
More Information Supplier PageCHC 250mg 250mg | Purity Not Available
Adooq Bioscience
CHC is a monocarboxylic acid transport (MCT) inhibitor. Exhibits antitumoral and antiangiogenic activity in gliomas; decreases glycolytic metabolism, migration, and invasion in U251 cells.
More Information Supplier PageCHC 1000mg 1000mg | Purity Not Available
Adooq Bioscience
CHC is a monocarboxylic acid transport (MCT) inhibitor. Exhibits antitumoral and antiangiogenic activity in gliomas; decreases glycolytic metabolism, migration, and invasion in U251 cells.
More Information Supplier Page